Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms

Infliximab has been proven to be an effective therapy in a miscellany of rheumatic diseases and has been approved for the treatment of moderate-to-severe Crohn's disease with an inadequate response to conventional therapy and for the management of enterocutaneous fistulas. Data about the role o...

Full description

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2004-06, Vol.36 (6), p.423-425
Main Authors: Lupascu, A, Armuzzi, A, De Pascalis, B, Carloni, E, Lauritano, E C, Gasbarrini, A, Pola, P
Format: Article
Language:English
Subjects:
Adult
Antibodies, Monoclonal - therapeutic use
Colitis, Ulcerative - complications
Colitis, Ulcerative - drug therapy
Female
Gastrointestinal Agents - therapeutic use
Humans
Infliximab
Sacroiliac Joint
Synovitis - drug therapy
Synovitis - etiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Infliximab has been proven to be an effective therapy in a miscellany of rheumatic diseases and has been approved for the treatment of moderate-to-severe Crohn's disease with an inadequate response to conventional therapy and for the management of enterocutaneous fistulas. Data about the role of infliximab in ulcerative colitis are still controversial. Here, we report a case of a patient with sacroileitis and peripheral arthropathy associated with left-sided ulcerative colitis who achieved a sustained clinical remission after infliximab therapy.
ISSN:1590-8658
DOI:10.1016/S1590-8658(04)00089-1